# Correcting Anemia and Native Vitamin D Supplementation in Kidney Transplant Recipients

Study · id `cardio:ct-nct01817699` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01817699](<https://clinicaltrials.gov/study/NCT01817699>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01817699

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 161 participants.

## Technical summary

Registry record NCT01817699. Randomized; no masking; primary purpose treatment. Start 2013-04 (actual); primary completion 2018-12 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 161 participants (enrolled count; ClinicalTrials.gov record NCT01817699, source copy `cardio:ctgov-nct01817699-2019-02-04`, retrieved 2026-10-26)
- Started: 2013-04 (actual) (ClinicalTrials.gov record NCT01817699, source copy `cardio:ctgov-nct01817699-2019-02-04`, retrieved 2026-10-26)
- Primary completion: 2018-12 (actual) (ClinicalTrials.gov record NCT01817699, source copy `cardio:ctgov-nct01817699-2019-02-04`, retrieved 2026-10-26)
- Completion: 2018-12 (actual) (ClinicalTrials.gov record NCT01817699, source copy `cardio:ctgov-nct01817699-2019-02-04`, retrieved 2026-10-26)
- Countries: Japan (ClinicalTrials.gov record NCT01817699, source copy `cardio:ctgov-nct01817699-2019-02-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01817699-2019-02-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: Correcting Anemia and Native Vitamin D Supplementation in Kidney Transplant Recipients
- Acronym: CANDLE-KIT
- Condition: Kidney Transplantation
- Condition: Anemia
- Condition: Vitamin D Deficiency
- Condition: Renal Insufficiency, Chronic
- Intervention (Other): High Hb target
- Intervention (Dietary supplement): cholecalciferol
- Lead sponsor: CANDLE-KIT Trial Study Group
- Lead sponsor class: OTHER
- Collaborator: Chugai Pharmaceutical
- Collaborator class: INDUSTRY
- Collaborator: Japanese Society for the Promotion of Science
- Collaborator class: OTHER
- Collaborator: The Japan Kidney Foundation
- Collaborator class: OTHER
- Collaborator: Roche Diagnostics GmbH
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)

## Provenance

Content hash: 71fb232e4f62981e74259548c39cd57a78053246ba2b572936f197649e66044a
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
